Fresenius Nominates Two Women to Board to Meet Gender Quotas

  • UCB's Loew-Friedrich, Deutsche Borse's Stars proposed
  • German company is among those not meeting board quotas

Fresenius SE headquarters.

Photographer: Ulf Schneider/Bloomberg

Fresenius SE, the largest publicly traded health-care provider in Europe, will nominate two women to its supervisory board as it seeks to meet government quotas for female representation.

Fresenius will propose to elect Iris Loew-Friedrich, chief medical officer at UCB SA, and Hauke Stars, a board member at Deutsche Boerse AG, as shareholder representatives at its annual general meeting on May 13, according to a statement Friday.

The company, based in Bad Homburg, Germany, is among the 22 percent of 200 biggest German companies that have no female board member or fail to meet quotas. Chancellor Angela Merkel’s government enforces a 30 percent quota for the supervisory boards.

Loew-Friedrich and Stars will join the other directors for a five-year term on the supervisory board. Gerd Krick will be proposed for re-election as Chairman.

Before it's here, it's on the Bloomberg Terminal.